KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to $1.9 billion.

  • Evolent Health's Non-Current Assets fell 379.97% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 billion, marking a year-over-year decrease of 301.29%. This contributed to the annual value of $1.9 billion for FY2024, which is 297.21% down from last year.
  • As of Q3 2025, Evolent Health's Non-Current Assets stood at $1.9 billion, which was down 379.97% from $1.9 billion recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Non-Current Assets peaked at $2.1 billion during Q1 2023, and registered a low of $775.3 million during Q3 2021.
  • For the 5-year period, Evolent Health's Non-Current Assets averaged around $1.6 billion, with its median value being $1.9 billion (2025).
  • Over the last 5 years, Evolent Health's Non-Current Assets had its largest YoY gain of 2310544.18% in 2021, and its largest YoY loss of 3313.04% in 2021.
  • Quarter analysis of 5 years shows Evolent Health's Non-Current Assets stood at $895.5 million in 2021, then skyrocketed by 49.55% to $1.3 billion in 2022, then soared by 49.09% to $2.0 billion in 2023, then fell by 2.97% to $1.9 billion in 2024, then decreased by 2.78% to $1.9 billion in 2025.
  • Its Non-Current Assets stands at $1.9 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $1.9 billion for Q1 2025.